Skip to content

A Study to know the effect of siddha medicine Nelli Vadagam in the treatment of Ottrai Thalaivali (Migraine)

Clinical Evaluation of Siddha herbal formulation Nelli Vadagam in the management of Ottrai Thalaivali (Migraine) among out-patients attending Ayothidoss Pandithar hospital National Institute of siddha - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070761
Enrollment
30
Registered
2024-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

Intervention1: Nelli Vadagam: A Compound herbal drug indicated to treat Ottrai Thalaivali (Migraine) adviced to intake 6grams for 48 days Control Intervention1: NIL: NIL

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Five migraine attacks, in the last 3 months each lasting for 4-72 hours and having any two of the following characteristics, a)Headache of unilateral location, b)Pulsating quality, c)Mild to moderate intensity d)Lacrimation with burning sensation of eyes e)Tiredness Patient must have at least any one of the following symptoms, a)Often accompanied by nausea (and/or vomiting). b)Sensitivity to light and sound. Headache Impact Test total score range 36-59 will be included Patient who is willing to participate in the study by signing consent and fulfilling the conditions of Proforma.

Exclusion criteria

Exclusion criteria: Patients with the H/O, Cervical spondylosis Cerebro vascular diseases Trigeminal neuralgia. Traumatic history Psychiatric illness Seizures Alcoholism Pregnancy Sinusitis headaches Ear disorders Refractive errors Cluster headache Patient with any other serious systemic diseases

Design outcomes

Primary

MeasureTime frame
Improvement of the clinical symptoms (assessed by HIT score) from the baseline.Timepoint: 48 days

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr T LAKSHMIKANTHAM

National Institute of siddha

drlakshmiramaswamy@gmail.com9025575185

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026